Proteomics in primary biliary cholangitis

You Li, Ruqui Tang, Patrick S Leung, M. Eric Gershwin, Xiong Ma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary biliary cholangitis is a chronic cholestatic liver disease characterized by the presence of serum antimitochondrial antibodies and immune-mediated destruction of the small and medium-sized intrahepatic bile ducts. However, the pathophysiology of primary biliary cholangitis has not yet been completely elucidated. In recent years, proteomics has been comprehensively applied in many research fields, including the pathogenesis, prognosis, and diagnosis of disease. Among multiple methods, isobaric tag for relative and absolute quantitation is a powerful analytic method to characterize complex protein mixtures in combination with liquid chromatography-tandem mass spectrometry. In this chapter, we describe a strategy for using isobaric tag for relative and absolute quantitation to discover those differentially expressed proteins in primary biliary cholangitis. The goal is to identify the differences in protein expression between patients with primary biliary cholangitis and healthy controls for defining biomarkers and elucidating molecular mechanisms underlying disease states.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages163-173
Number of pages11
DOIs
StatePublished - Jan 1 2019

Publication series

NameMethods in Molecular Biology
Volume1981
ISSN (Print)1064-3745

Fingerprint

Cholangitis
Proteomics
Intrahepatic Bile Ducts
Proteins
Tandem Mass Spectrometry
Complex Mixtures
Liquid Chromatography
Liver Diseases
Biomarkers
Antibodies
Serum
Research

Keywords

  • Bioinformatics
  • Differentially expressed proteins
  • Full-scan MS spectra
  • High pH reverse phase liquid chromatography (RHPLC)
  • Isobaric tag for relative and absolute quantitation (iTRAQ)
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
  • Plasma
  • Primary biliary cholangitis
  • Proteomics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Li, Y., Tang, R., Leung, P. S., Gershwin, M. E., & Ma, X. (2019). Proteomics in primary biliary cholangitis. In Methods in Molecular Biology (pp. 163-173). (Methods in Molecular Biology; Vol. 1981). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-9420-5_11

Proteomics in primary biliary cholangitis. / Li, You; Tang, Ruqui; Leung, Patrick S; Gershwin, M. Eric; Ma, Xiong.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 163-173 (Methods in Molecular Biology; Vol. 1981).

Research output: Chapter in Book/Report/Conference proceedingChapter

Li, Y, Tang, R, Leung, PS, Gershwin, ME & Ma, X 2019, Proteomics in primary biliary cholangitis. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1981, Humana Press Inc., pp. 163-173. https://doi.org/10.1007/978-1-4939-9420-5_11
Li Y, Tang R, Leung PS, Gershwin ME, Ma X. Proteomics in primary biliary cholangitis. In Methods in Molecular Biology. Humana Press Inc. 2019. p. 163-173. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-9420-5_11
Li, You ; Tang, Ruqui ; Leung, Patrick S ; Gershwin, M. Eric ; Ma, Xiong. / Proteomics in primary biliary cholangitis. Methods in Molecular Biology. Humana Press Inc., 2019. pp. 163-173 (Methods in Molecular Biology).
@inbook{1073bbb21aaa46948fb9e28eee3a79af,
title = "Proteomics in primary biliary cholangitis",
abstract = "Primary biliary cholangitis is a chronic cholestatic liver disease characterized by the presence of serum antimitochondrial antibodies and immune-mediated destruction of the small and medium-sized intrahepatic bile ducts. However, the pathophysiology of primary biliary cholangitis has not yet been completely elucidated. In recent years, proteomics has been comprehensively applied in many research fields, including the pathogenesis, prognosis, and diagnosis of disease. Among multiple methods, isobaric tag for relative and absolute quantitation is a powerful analytic method to characterize complex protein mixtures in combination with liquid chromatography-tandem mass spectrometry. In this chapter, we describe a strategy for using isobaric tag for relative and absolute quantitation to discover those differentially expressed proteins in primary biliary cholangitis. The goal is to identify the differences in protein expression between patients with primary biliary cholangitis and healthy controls for defining biomarkers and elucidating molecular mechanisms underlying disease states.",
keywords = "Bioinformatics, Differentially expressed proteins, Full-scan MS spectra, High pH reverse phase liquid chromatography (RHPLC), Isobaric tag for relative and absolute quantitation (iTRAQ), Liquid chromatography-tandem mass spectrometry (LC-MS/MS), Plasma, Primary biliary cholangitis, Proteomics",
author = "You Li and Ruqui Tang and Leung, {Patrick S} and Gershwin, {M. Eric} and Xiong Ma",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-9420-5_11",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "163--173",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Proteomics in primary biliary cholangitis

AU - Li, You

AU - Tang, Ruqui

AU - Leung, Patrick S

AU - Gershwin, M. Eric

AU - Ma, Xiong

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Primary biliary cholangitis is a chronic cholestatic liver disease characterized by the presence of serum antimitochondrial antibodies and immune-mediated destruction of the small and medium-sized intrahepatic bile ducts. However, the pathophysiology of primary biliary cholangitis has not yet been completely elucidated. In recent years, proteomics has been comprehensively applied in many research fields, including the pathogenesis, prognosis, and diagnosis of disease. Among multiple methods, isobaric tag for relative and absolute quantitation is a powerful analytic method to characterize complex protein mixtures in combination with liquid chromatography-tandem mass spectrometry. In this chapter, we describe a strategy for using isobaric tag for relative and absolute quantitation to discover those differentially expressed proteins in primary biliary cholangitis. The goal is to identify the differences in protein expression between patients with primary biliary cholangitis and healthy controls for defining biomarkers and elucidating molecular mechanisms underlying disease states.

AB - Primary biliary cholangitis is a chronic cholestatic liver disease characterized by the presence of serum antimitochondrial antibodies and immune-mediated destruction of the small and medium-sized intrahepatic bile ducts. However, the pathophysiology of primary biliary cholangitis has not yet been completely elucidated. In recent years, proteomics has been comprehensively applied in many research fields, including the pathogenesis, prognosis, and diagnosis of disease. Among multiple methods, isobaric tag for relative and absolute quantitation is a powerful analytic method to characterize complex protein mixtures in combination with liquid chromatography-tandem mass spectrometry. In this chapter, we describe a strategy for using isobaric tag for relative and absolute quantitation to discover those differentially expressed proteins in primary biliary cholangitis. The goal is to identify the differences in protein expression between patients with primary biliary cholangitis and healthy controls for defining biomarkers and elucidating molecular mechanisms underlying disease states.

KW - Bioinformatics

KW - Differentially expressed proteins

KW - Full-scan MS spectra

KW - High pH reverse phase liquid chromatography (RHPLC)

KW - Isobaric tag for relative and absolute quantitation (iTRAQ)

KW - Liquid chromatography-tandem mass spectrometry (LC-MS/MS)

KW - Plasma

KW - Primary biliary cholangitis

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=85065292020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065292020&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-9420-5_11

DO - 10.1007/978-1-4939-9420-5_11

M3 - Chapter

C2 - 31016654

AN - SCOPUS:85065292020

T3 - Methods in Molecular Biology

SP - 163

EP - 173

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -